CME Program Detail...
All-Cause Mortality Outcomes in RBV Monitoring
Date: Mon, Apr 4th, 2022
Time: 4:30 pm - 6:00 pm
Location: Online
Peter Kotanko,
Disclosures: None
Target Audience: physicians, fellows, residents, students
Dr. Kotanko has no relevant financial relationships to disclose.
> Outline the background of relative blood volume (RBV) monitoring used in hemodialysis patients.
> Provide an overview of how RBV monitoring can be beneficial for hemodialysis patients.
> Explain the impact of RBV monitoring as it relates to better survival for hemodialysis patients.
Accreditation
NewYork Presbyterian/Queens is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
NewYork Presbyterian/Queens designates this Live Activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY, CPME and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with
commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.
Grand Rounds
Department: Medicine
Specialty: Internal Medicine
Subspecialty: Nephrology
CME Credit Hours: 1.50
Event Sponsors:
NYPQ CME
